Covid-19: what you need to know today
The United States recorded 2,760 deaths on Wednesday, according to the New York Times. This is the highest daily death toll in the country since the start of the pandemic (warning: just like the death toll on any other day, this doesn’t mean 2,760 people died from Covid-19 on Wednesday, just that their deaths were recorded on that day).
There is a high probability that this number will increase in the coming days. According to the New York Times, hospitalizations in the US have exceeded 100,000. On Wednesday, the United States had 5.57 million infections, according to worldometers.info, a staggeringly high number, almost 40% of the total 14.3 million cases the country has seen so far.
- The third wave of infections in the US, the flood of hospitalizations and the flood of deaths can be attributed to the opening, the onset of winter and the holiday season. Experts also fear the impact of Thanksgiving, which they hope to start showing up later this week.
The country has seen just under 14 million cases, according to the NYT database (there has always been some divergence between the two readings). In the week ending December 2, the US saw 164,024 cases daily on average (based on the NYT database). Last week it surpassed the 200,000 case mark in terms of daily cases for the first time. The third wave of infections, the avalanche of hospitalizations and the avalanche of deaths can be attributed to the opening, the start of winter, the Christmas season: experts fear the impact of Thanksgiving, they hope to start showing up late. this week – and, of course, the stupidity of the people. Show me a super broadcast event and I’ll show you an idiot, maybe more. It’s going to be a long dark winter for America.
- However, sometime before December 15, the US Food and Drug Administration will almost certainly approve the country’s first Covid-19 vaccine. And before Christmas, I could pass the second. The agency is expected to make a decision on the vaccine developed by Pfizer and BioNTech on December 10, and on the one developed by Moderna on December 17.
However, sometime before December 15, the US Food and Drug Administration will almost certainly approve the country’s first Covid-19 vaccine. And before Christmas, I could pass the second. The agency is expected to make a decision (or at least critical steps to make an eventual decision) on the vaccine developed by Pfizer and BioNTech on December 10, and on the one developed by Moderna on December 17.
Given what we know from the trial results for both vaccines, regulatory approval for both is almost a certainty. The UK has already approved the Pfizer-BioNTech vaccine (this happened on Wednesday), and media reports in the US point to some level of distress that the FDA is taking its time. An AFP report quoted Moncef Slaoui, scientific adviser to Operation Warp Speed, the US government program that has invested billions of dollars in vaccine developers, probably the Trump administration’s greatest success, as saying that vaccines in the country could begin in mid-December and that by “the end of February, we will have potentially immunized 100 million people.”
Excluding those under the age of 18, who won’t get the vaccine until much later in the year (and this isn’t just in the US, but everywhere else; Dispatch 217 on Thursday explained why) , this will cover about 40% of those who need vaccinations. Earlier this week, the executive in charge of supply and distribution for Operation Warp Speed told MSNBC that all Americans who want vaccines will have them in June.
In both the UK and the US, which will be the first countries to start vaccinating people with vaccines that have passed Phase 3 trials, Russia and China are also vaccinating people in emergency situations, but the final results of the trials in the case are still awaited. Of the two vaccines approved by the first and all three by the second, the challenge for administrators and health officials is to convince everyone to get vaccinated. Both countries have a significant anti-vaccine population.
However, with the UK, US and other wealthy countries grabbing much of the vaccine supply, 2021 is likely to result in a new kind of inequality, and because vaccines are relevant from a vaccine perspective lives and livelihoods, this will only accentuate existing fractures. between the global north and the global south.